MRAP2 knockout mice lack the early-onset hyperphagia of MC4R knockout mice, and humans with MRAP2 genetic variants exhibit hyperglycaemia, hypertension and high blood cholesterol more frequently than those with MC4R mutations (6). Here, MRAP2 is linked to hypertensive disorder.